Trump administration nearing deal to lower prices of obesity drugs
The Trump administration is expected to announce this week a deal with drugmakers Eli Lilly and Novo Nordisk to lower the prices of their obesity drugs sold through TrumpRX.
Originally published by washingtontimes.com. Syndicated material does not necessarily reflect the views of Vanity Fair Fashion.
